MedTrace Logo

Regenerative Ability of TAMP BG and BD in Pulpotomized Primary Teeth

NCT03786302 · Status: TERMINATED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 102

Last updated 2020-10-14

No results posted yet for this study

Summary

The aim of this study was to assess clinically, radiographically, and histologically the regenerative ability of Tailored Amorphous Mulioporous (TAMP-BG) bioglass in comparison to Biodentine™ (BD) in pulpotomized primary teeth.

Conditions

  • Pulpotomy

Interventions

DRUG

TAMP bioglass

TAMP bioglass compared to Biodentine in the regeneration on pulpotomized primary teeth

DRUG

Biodentine

TAMP bioglass compared to Biodentine in the regeneration on pulpotomized primary teeth

Sponsors & Collaborators

  • Alexandria University

    collaborator OTHER

  • Nourhan M.Aly

    lead OTHER

Principal Investigators

  • Yasmine I El-Hamouly, MSc · Alexandria University

  • Karin ML Dowidar, PhD · Alexandria University

  • Samia Soliman, PhD · Alexandria University

  • Dalia AM Talaat, PhD · Alexandria University

  • Rania M El Backly, PhD · Alexandria University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
5 Years
Max Age
9 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-12-06
Primary Completion
2018-08-15
Completion
2018-10-20

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03786302 on ClinicalTrials.gov